268 related articles for article (PubMed ID: 26318045)
21. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
[TBL] [Abstract][Full Text] [Related]
22. Gli1 expression in pancreatic ductal adenocarcinoma and its clinical significance.
Abula Y; Yi C; Wang XY; Wang M; Qin RY; Guo YQ; Lin H; Li HJ
Genet Mol Res; 2015 Oct; 14(4):12323-9. PubMed ID: 26505381
[TBL] [Abstract][Full Text] [Related]
23. Annexin A8 Is a Prognostic Marker and Potential Therapeutic Target for Pancreatic Cancer.
Pimiento JM; Chen DT; Centeno BA; Davis-Yadley AH; Husain K; Fulp WJ; Wang C; Zhang A; Malafa MP
Pancreas; 2015 Jan; 44(1):122-7. PubMed ID: 25268673
[TBL] [Abstract][Full Text] [Related]
24. Aberrant NFATc1 signaling counteracts TGFβ-mediated growth arrest and apoptosis induction in pancreatic cancer progression.
Hasselluhn MC; Schmidt GE; Ellenrieder V; Johnsen SA; Hessmann E
Cell Death Dis; 2019 Jun; 10(6):446. PubMed ID: 31171768
[TBL] [Abstract][Full Text] [Related]
25. The long non-coding RNA HOTAIR affects the radiosensitivity of pancreatic ductal adenocarcinoma by regulating the expression of Wnt inhibitory factor 1.
Jiang Y; Li Z; Zheng S; Chen H; Zhao X; Gao W; Bi Z; You K; Wang Y; Li W; Li L; Liu Y; Chen R
Tumour Biol; 2016 Mar; 37(3):3957-67. PubMed ID: 26482614
[TBL] [Abstract][Full Text] [Related]
26. The prognostic significance and therapeutic potential of hedgehog signaling in intrahepatic cholangiocellular carcinoma.
Tang L; Tan YX; Jiang BG; Pan YF; Li SX; Yang GZ; Wang M; Wang Q; Zhang J; Zhou WP; Dong LW; Wang HY
Clin Cancer Res; 2013 Apr; 19(8):2014-24. PubMed ID: 23493353
[TBL] [Abstract][Full Text] [Related]
27. GLI1 facilitates the migration and invasion of pancreatic cancer cells through MUC5AC-mediated attenuation of E-cadherin.
Inaguma S; Kasai K; Ikeda H
Oncogene; 2011 Feb; 30(6):714-23. PubMed ID: 20972463
[TBL] [Abstract][Full Text] [Related]
28. Effects of bone sialoprotein on pancreatic cancer cell growth, invasion and metastasis.
Kayed H; Kleeff J; Keleg S; Felix K; Giese T; Berger MR; Büchler MW; Friess H
Cancer Lett; 2007 Jan; 245(1-2):171-83. PubMed ID: 16488077
[TBL] [Abstract][Full Text] [Related]
29. Involvement of angiotensin II type 2 receptor (AT2R) signaling in human pancreatic ductal adenocarcinoma (PDAC): a novel AT2R agonist effectively attenuates growth of PDAC grafts in mice.
Ishiguro S; Yoshimura K; Tsunedomi R; Oka M; Takao S; Inui M; Kawabata A; Wall T; Magafa V; Cordopatis P; Tzakos AG; Tamura M
Cancer Biol Ther; 2015; 16(2):307-16. PubMed ID: 25756513
[TBL] [Abstract][Full Text] [Related]
30. Kif20a inhibition reduces migration and invasion of pancreatic cancer cells.
Stangel D; Erkan M; Buchholz M; Gress T; Michalski C; Raulefs S; Friess H; Kleeff J
J Surg Res; 2015 Jul; 197(1):91-100. PubMed ID: 25953216
[TBL] [Abstract][Full Text] [Related]
31. SUFU promotes GLI activity in a Hedgehog-independent manner in pancreatic cancer.
Paradise BD; Gainullin VG; Almada LL; Sigafoos AN; Sen S; Vera RE; Raja Arul GL; Toruner M; Pease DR; Gonzalez AL; Mentucci FM; Grasso DH; Fernandez-Zapico ME
Biochem J; 2023 Aug; 480(15):1199-1216. PubMed ID: 37477952
[TBL] [Abstract][Full Text] [Related]
32. FOXC2 is up-regulated in pancreatic ductal adenocarcinoma and promotes the growth and migration of cancer cells.
Cui L; Dang S; Qu J; Mao Z; Wang X; Zhang J; Chen J
Tumour Biol; 2016 Jul; 37(7):8579-85. PubMed ID: 26733175
[TBL] [Abstract][Full Text] [Related]
33. Enhancer of zeste homolog 2 silences microRNA-218 in human pancreatic ductal adenocarcinoma cells by inducing formation of heterochromatin.
Li CH; To KF; Tong JH; Xiao Z; Xia T; Lai PB; Chow SC; Zhu YX; Chan SL; Marquez VE; Chen Y
Gastroenterology; 2013 May; 144(5):1086-1097.e9. PubMed ID: 23395645
[TBL] [Abstract][Full Text] [Related]
34. Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor beta1- and slug-dependent: role in malignant transformation of pancreatic cancer.
Geismann C; Morscheck M; Koch D; Bergmann F; Ungefroren H; Arlt A; Tsao MS; Bachem MG; Altevogt P; Sipos B; Fölsch UR; Schäfer H; Müerköster SS
Cancer Res; 2009 May; 69(10):4517-26. PubMed ID: 19435915
[TBL] [Abstract][Full Text] [Related]
35. Down-regulation of the zinc-finger homeobox protein TSHZ2 releases GLI1 from the nuclear repressor complex to restore its transcriptional activity during mammary tumorigenesis.
Riku M; Inaguma S; Ito H; Tsunoda T; Ikeda H; Kasai K
Oncotarget; 2016 Feb; 7(5):5690-701. PubMed ID: 26744317
[TBL] [Abstract][Full Text] [Related]
36. SOX9 inhibits β-TrCP-mediated protein degradation to promote nuclear GLI1 expression and cancer stem cell properties.
Deng W; Vanderbilt DB; Lin CC; Martin KH; Brundage KM; Ruppert JM
J Cell Sci; 2015 Mar; 128(6):1123-38. PubMed ID: 25632159
[TBL] [Abstract][Full Text] [Related]
37. Nuclear death receptor TRAIL-R2 inhibits maturation of let-7 and promotes proliferation of pancreatic and other tumor cells.
Haselmann V; Kurz A; Bertsch U; Hübner S; Olempska-Müller M; Fritsch J; Häsler R; Pickl A; Fritsche H; Annewanter F; Engler C; Fleig B; Bernt A; Röder C; Schmidt H; Gelhaus C; Hauser C; Egberts JH; Heneweer C; Rohde AM; Böger C; Knippschild U; Röcken C; Adam D; Walczak H; Schütze S; Janssen O; Wulczyn FG; Wajant H; Kalthoff H; Trauzold A
Gastroenterology; 2014 Jan; 146(1):278-90. PubMed ID: 24120475
[TBL] [Abstract][Full Text] [Related]
38. Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer.
Shimazaki R; Takano S; Satoh M; Takada M; Miyahara Y; Sasaki K; Yoshitomi H; Kagawa S; Furukawa K; Takayashiki T; Kuboki S; Sogawa K; Motohashi S; Nomura F; Miyazaki M; Ohtsuka M
Cell Oncol (Dordr); 2021 Aug; 44(4):937-950. PubMed ID: 34075561
[TBL] [Abstract][Full Text] [Related]
39. The anti-oxidative transcription factor Nuclear factor E2 related factor-2 (Nrf2) counteracts TGF-β1 mediated growth inhibition of pancreatic ductal epithelial cells -Nrf2 as determinant of pro-tumorigenic functions of TGF-β1.
Genrich G; Kruppa M; Lenk L; Helm O; Broich A; Freitag-Wolf S; Röcken C; Sipos B; Schäfer H; Sebens S
BMC Cancer; 2016 Feb; 16():155. PubMed ID: 26915435
[TBL] [Abstract][Full Text] [Related]
40. SCL/TAL1 interrupting locus derepresses GLI1 from the negative control of suppressor-of-fused in pancreatic cancer cell.
Kasai K; Inaguma S; Yoneyama A; Yoshikawa K; Ikeda H
Cancer Res; 2008 Oct; 68(19):7723-9. PubMed ID: 18829525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
